157 related articles for article (PubMed ID: 32449085)
1. Targeted Gene Silencing BRAF Synergized Photothermal Effect Inhibits Hepatoma Cell Growth Using New GAL-GNR-siBRAF Nanosystem.
Liu Y; Tan M; Zhang Y; Huang W; Min L; Peng S; Yuan K; Qiu L; Min W
Nanoscale Res Lett; 2020 May; 15(1):116. PubMed ID: 32449085
[TBL] [Abstract][Full Text] [Related]
2. Targeted-gene silencing of BRAF to interrupt BRAF/MEK/ERK pathway synergized photothermal therapeutics for melanoma using a novel FA-GNR-siBRAF nanosystem.
Zhang Y; Zhan X; Peng S; Cai Y; Zhang YS; Liu Y; Wang Z; Yu Y; Wang Y; Shi Q; Zeng X; Yuan K; Zhou N; Joshi R; Zhang M; Zhang Z; Min W
Nanomedicine; 2018 Jul; 14(5):1679-1693. PubMed ID: 29684526
[TBL] [Abstract][Full Text] [Related]
3. A novel multifunctional gold nanorod-mediated and tumor-targeted gene silencing of GPC-3 synergizes photothermal therapy for liver cancer.
Liu Y; Tan M; Fang C; Chen X; Liu H; Feng Y; Zhang Y; Min W
Nanotechnology; 2021 Apr; 32(17):175101. PubMed ID: 33445163
[TBL] [Abstract][Full Text] [Related]
4. Biomineralized Polydopamine Nanoparticle-Based Sodium Alginate Hydrogels for Delivery of Anti-serine/Threonine Protein Kinase B-Rapidly Accelerated Fibrosarcoma siRNA for Metastatic Melanoma Therapy.
Lu J; Song J; Zhang P; Huang Y; Lu X; Dai H; Xi J
ACS Nano; 2023 Sep; 17(18):18318-18331. PubMed ID: 37690074
[TBL] [Abstract][Full Text] [Related]
5. Coated microneedles mediated intradermal delivery of octaarginine/BRAF siRNA nanocomplexes for anti-melanoma treatment.
Ruan W; Zhai Y; Yu K; Wu C; Xu Y
Int J Pharm; 2018 Dec; 553(1-2):298-309. PubMed ID: 30347273
[TBL] [Abstract][Full Text] [Related]
6. Dendritic Cell-Derived Exosomes Driven Drug Co-Delivery Biomimetic Nanosystem for Effective Combination of Malignant Melanoma Immunotherapy and Gene Therapy.
Lin J; Huang N; Li M; Zheng M; Wang Z; Zhang X; Gao H; Lao Y; Zhang J; Ding B
Drug Des Devel Ther; 2023; 17():2087-2106. PubMed ID: 37489176
[TBL] [Abstract][Full Text] [Related]
7. Multifunctional gold nanorods in low-temperature photothermal interactions for combined tumor starvation and RNA interference therapy.
Fan R; Chen C; Hu J; Mu M; Chuan D; Chen Z; Guo G; Xu J
Acta Biomater; 2023 Mar; 159():324-337. PubMed ID: 36706851
[TBL] [Abstract][Full Text] [Related]
8. A dual-targeted hyaluronic acid-gold nanorod platform with triple-stimuli responsiveness for photodynamic/photothermal therapy of breast cancer.
Xu W; Qian J; Hou G; Wang Y; Wang J; Sun T; Ji L; Suo A; Yao Y
Acta Biomater; 2019 Jan; 83():400-413. PubMed ID: 30465921
[TBL] [Abstract][Full Text] [Related]
9. A new cancer immunotherapy via simultaneous DC-mobilization and DC-targeted IDO gene silencing using an immune-stimulatory nanosystem.
Zhang Y; Fu J; Shi Y; Peng S; Cai Y; Zhan X; Song N; Liu Y; Wang Z; Yu Y; Wang Y; Shi Q; Fu Y; Yuan K; Zhou N; Joshi R; Ichim TE; Min W
Int J Cancer; 2018 Oct; 143(8):2039-2052. PubMed ID: 29752722
[TBL] [Abstract][Full Text] [Related]
10. Galactosylated Liposomes for Targeted Co-Delivery of Doxorubicin/Vimentin siRNA to Hepatocellular Carcinoma.
Oh HR; Jo HY; Park JS; Kim DE; Cho JY; Kim PH; Kim KS
Nanomaterials (Basel); 2016 Jul; 6(8):. PubMed ID: 28335269
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of galectin-3 causes a decrease in uPAR levels and inhibits the proliferation, migration and invasion of hepatocellular carcinoma cells.
Zheng D; Hu Z; He F; Gao C; Xu L; Zou H; Wu Z; Jiang X; Wang J
Oncol Rep; 2014 Jul; 32(1):411-8. PubMed ID: 24807674
[TBL] [Abstract][Full Text] [Related]
12. Tetrahedral Framework Nucleic Acids Loaded with Aptamer AS1411 for siRNA Delivery and Gene Silencing in Malignant Melanoma.
Xiao D; Li Y; Tian T; Zhang T; Shi S; Lu B; Gao Y; Qin X; Zhang M; Wei W; Lin Y
ACS Appl Mater Interfaces; 2021 Feb; 13(5):6109-6118. PubMed ID: 33497198
[TBL] [Abstract][Full Text] [Related]
13. Gold nanorods decorated with a cancer drug for multimodal imaging and therapy.
Nair RV; Santhakumar H; Jayasree RS
Faraday Discuss; 2018 Apr; 207():423-435. PubMed ID: 29355869
[TBL] [Abstract][Full Text] [Related]
14. Photothermal conversion efficiency and cytotoxic effect of gold nanorods stabilized with chitosan, alginate and poly(vinyl alcohol).
Almada M; Leal-Martínez BH; Hassan N; Kogan MJ; Burboa MG; Topete A; Valdez MA; Juárez J
Mater Sci Eng C Mater Biol Appl; 2017 Aug; 77():583-593. PubMed ID: 28532069
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-targeted gold nanorods for cancer photothermal therapy.
Chen Y; Bian X; Aliru M; Deorukhkar AA; Ekpenyong O; Liang S; John J; Ma J; Gao X; Schwartz J; Singh P; Ye Y; Krishnan S; Xie H
Oncotarget; 2018 May; 9(41):26556-26571. PubMed ID: 29899876
[TBL] [Abstract][Full Text] [Related]
16. Synergistic Chemo-Photothermal Therapy of Breast Cancer by Mesenchymal Stem Cell-Encapsulated Yolk-Shell GNR@HPMO-PTX Nanospheres.
Wu J; Liu Y; Tang Y; Wang S; Wang C; Li Y; Su X; Tian J; Tian Y; Pan J; Su Y; Zhu H; Teng Z; Lu G
ACS Appl Mater Interfaces; 2016 Jul; 8(28):17927-35. PubMed ID: 27356586
[TBL] [Abstract][Full Text] [Related]
17. Biologically Inspired Polydopamine Capped Gold Nanorods for Drug Delivery and Light-Mediated Cancer Therapy.
Wang S; Zhao X; Wang S; Qian J; He S
ACS Appl Mater Interfaces; 2016 Sep; 8(37):24368-84. PubMed ID: 27564325
[TBL] [Abstract][Full Text] [Related]
18. Nucleolin-targeting liposomes guided by aptamer AS1411 for the delivery of siRNA for the treatment of malignant melanomas.
Li L; Hou J; Liu X; Guo Y; Wu Y; Zhang L; Yang Z
Biomaterials; 2014 Apr; 35(12):3840-50. PubMed ID: 24486214
[TBL] [Abstract][Full Text] [Related]
19. Gold nanorod embedded large-pore mesoporous organosilica nanospheres for gene and photothermal cooperative therapy of triple negative breast cancer.
Ni Q; Teng Z; Dang M; Tian Y; Zhang Y; Huang P; Su X; Lu N; Yang Z; Tian W; Wang S; Liu W; Tang Y; Lu G; Zhang L
Nanoscale; 2017 Jan; 9(4):1466-1474. PubMed ID: 28066849
[TBL] [Abstract][Full Text] [Related]
20. Preparation of PEG-modified PAMAM dendrimers having a gold nanorod core and their application to photothermal therapy.
Li X; Takeda K; Yuba E; Harada A; Kono K
J Mater Chem B; 2014 Jul; 2(26):4167-4176. PubMed ID: 32261750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
